Abstract
Dyslipidemia is an important etiologic factor in the development of cardiovascular disease (CVD), which is a leading cause of death worldwide As CVD begins in childhood, and as dyslipidemia is an important risk factor for CVD, screening and treatment of dyslipidemia in adolescents and children becomes an important health matter. This review deals with issues related to screening, diagnosis and treatment of dyslipidemia in children and adolescents.
Highlights
Dyslipidemia is an important etiologic factor in the development of cardiovascular disease (CVD), which is a leading cause of death worldwide [1]
Studies reveal that CVD begins in childhood [2,3] and endothelial damage has been noted in the first few years of life in children with lipid abnormalities [4,5]
School nurses can be utilized to spread these, and other, messages related to prevention of CVD
Summary
Dyslipidemia is an important etiologic factor in the development of cardiovascular disease (CVD), which is a leading cause of death worldwide [1]. This, associated with unhealthy diet, lack of physical activity and weight gain, [6,7], makes screening and treatment of dyslipidemia in adolescents and children an important target for prevention of CVD and mortality. An LDL value of 110-129 mg% will classify as 'borderline', and will prompt diet (American Heart Association (AHA) step I) [10] and lifestyle management, as well as a repeat lipoprotein analysis after 1 year. No pharmacological lipid- lowering therapy is indicated in these children or adolescents.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
